Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values

Diagnostic Microbiology and Infectious Disease

Volumn 73, Issue 4, 2012, Pages 365-368

  Pfaller, M A ^a,b   Chaturvedi, V ^c   Diekema, D J ^a   Ghannoum, M A ^d   Holliday, N M ^e   Killian, S B ^e   Knapp, C C ^e   Messer, S A ^a,b   Miskou, A ^e   Ramani, R ^c  

^a UNIVERSITY OF IOWA   (United States)

^b JMI LABORATORIES   (United States)

^c NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

^e Trek Diagnostic Systems   (United States)

Author keywords

Candida; CLSI Sensititre YeastOne; Echinocandins; In vitro susceptibility testing

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CLAVISPORA LUSITANIAE; CLINICAL AND LABORATORY STANDARDS INSTITUTE MICRODILUTION; COLORIMETRY; CONTROLLED STUDY; DRIED COLORIMETRIC ANTIFUNGAL PANEL; FUNGAL EXAMINATION; FUNGAL STRAIN; FUNGUS ISOLATION; INCUBATION TIME; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCIBILITY; SPECIES DIFFERENCE;

ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS; COLORIMETRY; ECHINOCANDINS; HUMANS; MICROBIAL SENSITIVITY TESTS; UNITED STATES;

EID: 84863783783     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.05.008     Document Type: Article

References (19)

1. Alexander B.D., Byrne T.C., Smith K.L., et al. Comparative evaluation of Etest and Sensititre YeastOne panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents. J Clin Microbiol 2007, 45:698-706.
2. Arendrup M.C., Garcia-Effron G., Lass-Florl C., et al. Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media. Antimicrob Agents Chemother 2010, 54:426-439.
3. Castanheira M., et al. Low prevalence of fks 1 hotspot 1 mutations in a worldwide collection of Candida strains. Antimicrob Agents Chemother 2010, 54:2655-2659.
4. Clinical and Laboratory Standards Institute (CLSI) Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard, third edition, M27-A3 2008, CLSI, Wayne, PA.
5. Clinical and Laboratory Standards Institute (CLSI) Reference method for broth dilution antifungal susceptibility testing of yeasts: 3rd informational supplement (M27-S3) 2008, CLSI, Wayne, PA.
6. Cuenca-Estrella M., Gomez-Lopez A., Alastruey-Izquierdo A., et al. Comparison of the Vitek 2 Antifungal Susceptibility System with the Clinical Laboratory Standards Institute (CLSI) and European Committee on Antifungal Susceptibility Testing (EUCAST) broth microdilution reference methods and with the Sensititre YeastOne and Etest techniques for in vitro detection of antifungal resistance in yeast isolates. J Clin Microbiol 2010, 48:1782-1786.
7. Espinel-Ingroff A., Pfaller M., Messer S.A., et al. Multicenter comparison of the Sensititre YeastOne Colorimetric antifungal panel with the National Committee for Clinical Laboratory Standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp. and other yeasts and yeast-like organisms. J Clin Microbiol 1999, 37:591-595.
8. Espinel-Ingroff A., Pfaller M., Messer S.A., et al. Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp. J Clin Microbiol 2004, 42:718-721.
9. Garcia-Effron G., Lee S., Park A., Cleary J.D., Perlin D.S. Effect of Candida glabrata FKS 1 and FKS 2 mutations on echinocandin sensitivity and kinetics of 1,3-β-d-glucan synthase: implications for existing susceptibility breakpoints. Antimicrob Agents Chemother 2009, 53:3690-3699.
10. Hazen K.C., Howell S.A. Candida, Cryptococcus, and other yeasts of medical importance. Manual of clinical microbiology 2007, 1762-1788. ASM Press, Washington DC. 9th ed. P.R. Murray, E.J. Baron, J.H. Jorgensen, M.L. Laudry, M.A. Pfaller (Eds.).
11. Pfaller M.A. New developments in the antifungal susceptibility testing of Candida. Curr Fungal Infect Rep 2008, 2:125-133.
12. Pfaller M.A., Espinel-Ingroff A., Jones R.N. Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazole. J Clin Microbiol 2004, 42:4577-4580.
13. Pfaller M.A., Jones R.N. Performance accuracy of antibacterial and antifungal susceptibility test methods: report form the College of American Pathologists microbiology surveys program (2001-2003). Arch Pathol Lab Med 2006, 130:767-778.
14. Pfaller M.A., Diekema D.J., Ostrosky-Zeichner L., et al. Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. J Clin Microbiol 2008, 46:2620-2629.
15. Pfaller M.A., Chaturvedi V., Diekema D.J., et al. Clinical evaluation of the Sensititre YeastOne Colorimetric Antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin. J Clin Microbiol 2008, 46:2155-2159.
16. Pfaller M.A., Boyken L., Hollis R.J., et al. Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp. J Clin Microbiol 2010, 4:52-56.
17. Pfaller M.A., Castanheira M., Diekema D.J., et al. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species. J Clin Microbiol 2010, 48:1592-1599.
18. Pfaller M.A., Diekema D.J., Andes D., et al. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist Updat 2011, 14:164-176.
19. Zimbeck A.J., Iqbal N., Ahlquist A.M., et al. FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance. Antimicrob Agents Chemother 2010, 54:5042-5047.